Barberi-Heyob M - Search Results

1

Modulation of photosensitization processes for an improved targeted photodynamic therapy.

Verhille M, Couleaud P, Vanderesse R, Brault D, Barberi-Heyob M, Frochot C. Verhille M, et al. Curr Med Chem. 2010;17(32):3925-43. doi: 10.2174/092986710793205453. Curr Med Chem. 2010. PMID: 20858211 Review.

2

New glycosylated porphyrins for PDT applications.

Frochot C, Di Stasio B, Barberi-Heyob M, Carre MC, Zwier JM, Guillemin F, Viriot ML. Frochot C, et al. Oftalmologia. 2003;56(1):62-6. Oftalmologia. 2003. PMID: 12886686

3

Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.

Schneider R, Schmitt F, Frochot C, Fort Y, Lourette N, Guillemin F, Müller JF, Barberi-Heyob M. Schneider R, et al. Bioorg Med Chem. 2005 Apr 15;13(8):2799-808. doi: 10.1016/j.bmc.2005.02.025. Bioorg Med Chem. 2005. PMID: 15781391

4

The 2-aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin.

Di Stasio B, Frochot C, Dumas D, Even P, Zwier J, Müller A, Didelon J, Guillemin F, Viriot ML, Barberi-Heyob M. Di Stasio B, et al. Eur J Med Chem. 2005 Nov;40(11):1111-22. doi: 10.1016/j.ejmech.2005.04.007. Epub 2005 Jun 15. Eur J Med Chem. 2005. PMID: 15963605

5

A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.

Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M. Tirand L, et al. J Control Release. 2006 Mar 10;111(1-2):153-64. doi: 10.1016/j.jconrel.2005.11.017. Epub 2006 Jan 19. J Control Release. 2006. PMID: 16423422

6

Recent improvements in the use of synthetic peptides for a selective photodynamic therapy.

Schneider R, Tirand L, Frochot C, Vanderesse R, Thomas N, Gravier J, Guillemin F, Barberi-Heyob M. Schneider R, et al. Anticancer Agents Med Chem. 2006 Sep;6(5):469-88. doi: 10.2174/187152006778226503. Anticancer Agents Med Chem. 2006. PMID: 17017856 Review.

7

Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.

Frochot C, Di Stasio B, Vanderesse R, Belgy MJ, Dodeller M, Guillemin F, Viriot ML, Barberi-Heyob M. Frochot C, et al. Bioorg Chem. 2007 Jun;35(3):205-20. doi: 10.1016/j.bioorg.2006.11.005. Epub 2006 Dec 9. Bioorg Chem. 2007. PMID: 17223161

8

Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.

Tirand L, Thomas N, Dodeller M, Dumas D, Frochot C, Maunit B, Guillemin F, Barberi-Heyob M. Tirand L, et al. Drug Metab Dispos. 2007 May;35(5):806-13. doi: 10.1124/dmd.106.013763. Epub 2007 Feb 5. Drug Metab Dispos. 2007. PMID: 17283031

9

Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy.

Taquet JP, Frochot C, Manneville V, Barberi-Heyob M. Taquet JP, et al. Curr Med Chem. 2007;14(15):1673-87. doi: 10.2174/092986707780830970. Curr Med Chem. 2007. PMID: 17584072

10

Practical identifiability of photophysical parameters in photodynamic therapy.

Dobre S, Bastogne T, Barberi-Heyob M, Richard A. Dobre S, et al. Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:6633-6. doi: 10.1109/IEMBS.2007.4353880. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18003546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters